BROOKLYN IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 114082900. A total of 2 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 5,200 | -35.0% | 0.00% | – |
| Q2 2022 | $4,000 | -87.1% | 8,000 | -47.4% | 0.00% | – |
| Q1 2022 | $31,000 | -49.2% | 15,200 | +2.7% | 0.00% | – |
| Q4 2021 | $61,000 | -67.7% | 14,800 | +33.3% | 0.00% | – |
| Q3 2021 | $189,000 | -2.6% | 11,100 | +2.8% | 0.00% | – |
| Q2 2021 | $194,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 25,100 | $452,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,800 | $194,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |